The present study evaluated whether inhibiting AMPK and activating mTOR could stop metformin from improving memory in rats with streptozotocin (STZ) -induced Alzheimer’s disease. The gene discussed is MTOR; the disease is early-onset autosomal dominant Alzheimer disease.